abstract |
A method of treating childhood cancer in a subject in need of treatment. The method comprises administering to the subject a therapeutically effective amount of (S) -N- (5 - ((R) -2- (2,5- difluorophenyl) pyrrolidin- 5-a] pyrimidin-3-yl) -3-hydroxypyrrolidine-1-carboxamide, or a pharmaceutically acceptable salt thereof, or a combination thereof. |